What are the physical findings of papulopustular drug eruption due to EGF-R?

Updated: Oct 08, 2020
  • Author: Elizabeth K Satter, MD, MPH; Chief Editor: Dirk M Elston, MD  more...
  • Print

Papulopustular drug eruption due to EGF-R is a relatively new entity and consists of a follicular eruption on the face, chest, and upper back that occurs approximately 2 weeks after initiation of chemotherapy. It is seen in up to 90% of patients taking EGF-R inhibitors, and its presence correlates to a positive response to chemotherapy. [7, 8, 22] Effective management can be critical to compliance with the anticancer treatment regimen.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!